Cargando…
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
BACKGROUND: Immunocompromised individuals are highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Whether vaccine-induced immunity in these individuals involves oral cavity, a primary site of infection, is presently unknown. METHODS: Immunocompromised patien...
Autores principales: | Healy, Katie, Pin, Elisa, Chen, Puran, Söderdahl, Gunnar, Nowak, Piotr, Mielke, Stephan, Hansson, Lotta, Bergman, Peter, Smith, C.I. Edvard, Ljungman, Per, Valentini, Davide, Blennow, Ola, Österborg, Anders, Gabarrini, Giorgio, Al-Manei, Khaled, Alkharaan, Hassan, Sobkowiak, Michał Jacek, Yousef, Jamil, Mravinacova, Sara, Cuapio, Angelica, Xu, Xinling, Akber, Mira, Loré, Karin, Hellström, Cecilia, Muschiol, Sandra, Bogdanovic, Gordana, Buggert, Marcus, Ljunggren, Hans-Gustaf, Hober, Sophia, Nilsson, Peter, Aleman, Soo, Sällberg Chen, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770252/ https://www.ncbi.nlm.nih.gov/pubmed/35075450 http://dx.doi.org/10.1016/j.medj.2022.01.001 |
Ejemplares similares
-
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
por: Chen, Puran, et al.
Publicado: (2023) -
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
por: Ghorbani, Mahin, et al.
Publicado: (2023) -
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
por: Bergman, Peter, et al.
Publicado: (2021) -
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals
por: Cuapio, Angelica, et al.
Publicado: (2022) -
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
por: Gao, Yu, et al.
Publicado: (2022)